Edwin Jonathan Tucker - 12 Jun 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Chief Medical Officer
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
12 Jun 2023
Net transactions value
$0
Form type
4
Filing time
13 Jun 2023, 20:45:25 UTC
Previous filing
15 Nov 2021
Next filing
20 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +400,000 $0.000000 400,000 12 Jun 2023 Voting Common Stock 400,000 $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on June 12, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.